NPC(SH:600713)2018-04-25 16:00Financial Performance - Operating revenue for the period was CNY 7.53 billion, a 12.64% increase year-on-year[6] - Net profit attributable to shareholders was CNY 66.27 million, up 10.64% from the same period last year[6] - The company's tax and additional fees increased by 64.08% year-on-year, amounting to RMB 14,995,636.59, primarily due to sales growth[14] - Financial expenses rose by 37.35% year-on-year to RMB 83,769,591.65, attributed to increased financing scale and rising interest rates[14] - Total operating revenue for Q1 2018 was CNY 7,527,328,036.20, an increase of 12.6% compared to CNY 6,682,714,328.28 in Q1 2017[40] - Net profit for Q1 2018 reached CNY 79,716,403.34, representing a 7.2% increase from CNY 74,102,117.20 in Q1 2017[41] - The total profit for the current period was ¥24,607,257.26, up 56.3% from ¥15,771,545.66 in the previous period[45] Asset and Liability Changes - Total assets increased by 13.45% to CNY 18.07 billion compared to the end of the previous year[6] - The company's total liabilities reached CNY 13,879,161,430.18, compared to CNY 12,738,684,465.19 at the beginning of the year, which is an increase of about 8.9%[33] - The company reported a total current liability of CNY 13,648,880,576.88, up from CNY 12,508,385,120.48, indicating an increase of about 9.1%[32] - The company's cash and cash equivalents increased to CNY 2,060,108,285.52 from CNY 1,774,082,537.09, reflecting a growth of about 16.1%[31] - Accounts receivable rose to CNY 8,631,469,327.18, up from CNY 6,830,363,580.58, indicating an increase of approximately 26.4%[31] - Inventory levels increased to CNY 2,952,080,963.09 from CNY 2,636,061,205.20, marking a growth of around 11.9%[31] Cash Flow Analysis - The net cash flow from operating activities was negative at CNY -1.28 billion, compared to CNY -998.78 million in the previous year[6] - The net cash flow from operating activities decreased to -RMB 1,275,969,724.94, compared to -RMB 998,777,430.08 in the previous period[15] - The net cash flow from investment activities improved to RMB 22,951,761.01, a significant increase from -RMB 9,400,724.25 in the previous period[15] - The net cash flow from financing activities increased by 29.76% to RMB 1,426,668,621.93, mainly due to a non-public stock issuance raising RMB 939 million[15] - Cash inflow from financing activities totaled 5,555,648,555.46 CNY, compared to 2,967,352,200.07 CNY previously[53] - Cash outflow from financing activities was 4,174,831,834.26 CNY, an increase from 1,875,001,221.73 CNY year-over-year[53] Shareholder Information - Net assets attributable to shareholders increased by 35.45% to CNY 3.76 billion compared to the end of the previous year[6] - Basic and diluted earnings per share remained unchanged at CNY 0.067[6] - The total number of shareholders reached 73,125 by the end of the reporting period[10] - The equity attributable to the parent company increased to CNY 3,762,533,195.75 from CNY 2,777,721,431.60, reflecting a growth of approximately 35.4%[33] Strategic Initiatives - The company is actively pursuing strategic acquisitions to enhance its market position and expand its pharmaceutical supply chain resources[26] - The company completed a private placement raising CNY 939 million, contributing to the increase in capital reserves by 68.88%[13] - The company signed a letter of intent on April 9, 2018, to acquire at least 51% of the shares of Nanjing Huadong Pharmaceutical Co., Ltd. from its shareholders, including Jinling Pharmaceutical Co., Ltd.[26] Project Updates - The logistics center project is currently in the interior decoration phase, with equipment installation ongoing as per schedule[23] - The company received a total of RMB 1.148 billion in compensation for land and property expropriation from the Nanjing government[24] - The company has received partial compensation of RMB 1.3 billion for land and property expropriation in Yancheng, Jiangsu[24] Credit Rating - The company’s credit rating was upgraded to AA+ with a stable outlook by China Chengxin International Credit Rating Co., Ltd.[20]